References
- D. M. Williams, Clinical pharmacology of corticosteroids, Respircare 63(6) (2018) 655–670; https://doi.org/10.4187/respcare.06314
- T. K. Bergmann, K. A. Barraclough, K. J. Lee and C. E. Staatz, Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation, Clin. Pharmacokinet. 51 (2012) 711–741; https://doi.org/10.1007/s40262-012-0007-8
- I. Sæves, P. D. Line and S. Bergan, The pharmacokinetics of prednisolone and prednisone in adult liver transplant recipients early after transplantation, Ther. Drug Monit. 34(4) (2012) 452–459; https://doi.org/10.1097/FTD.0b013e31825ee3f8
- S. A. Gaballa, U. B. Kompella, O. Elgarhy, A. M. Alqahtani, B. Pierscionek, R. G. Alany and H. Abdelkader, Corticosteroids in ophthalmology: Drug delivery innovations, pharmacology, clinical applications, and future perspectives, Drug Deliv. Transl. Res. 11 (2021) 866–893; https://doi.org/10.1007/s13346-020-00843-z
- L. Nižić, I. Ugrina, D. Špoljarić, V. Saršon, M. S. Kučuk, I. Pepić and A. Hafner, Innovative sprayable in situ gelling fluticsone suspension: Development and optimization of nasal deposition, Int. J. Pharm. 563 (2019) 445–456; https://doi.org/10.1016/j.ijpharm.2019.04.015
- L. Nižić Nodilo, I. Ugrina, D. Špoljarić, D. Amidžić Klarić, C. Jakobušić Brala, M. Perkušić, I. Pepić, J. Lovrić, V. Saršon, M. Safundžić Kučuk, D. Zadravec, L. Kalogjera and A. Hafner, A dry powder platform for nose-to-brain delivery of dexamethasone: Formulation development and nasal deposition studies, Pharmaceutics 13(6) (2021) Article ID 795 (30 pages); https://doi.org/10.3390/pharmaceutics13060795
- L. Nižić Nodilo, M. Perkušić, I. Ugrina, D. Špoljarić, C. Jakobušić Brala, D. Amidžić Klarić, J. Lovrić, V. Saršon, M. Safundžić Kučuk, D. Zadravec, L. Kalogjera, I. Pepić and A. Hafner, In situ gelling nanosuspension as an advanced platform for fluticasone propionate nasal delivery, Eur. J. Pharm. Biopharm. 175 (2022) 27–42; https://doi.org/10.1016/j.ejpb.2022.04.009
- M. Perkušić, L. Nižić Nodilo, I. Ugrina, D. Špoljarić, C. Jakobušić Brala, I. Pepić, J. Lovrić, G. Matijašić, M. Gretić, D. Zadravec, L. Kalogjera and A. Hafner, Tailoring functional spray-dried powder platform for efficient donepezil nose-to-brain delivery, Int. J. Pharm. 624 (2022) Article ID 122038 (15 pages); https://doi.org/10.1016/j.ijpharm.2022.122038
- R. Kashyap, E. V. S. Subrahmanyam and A. R. Sharbaraya, Development and validation of UV spectroscopy method for the estimation of prednisolone in bulk and dosage form, J. Chem. Pharm. Res. 4(2) (2012) 1090–1096.
- S. Mazurek and R. Szostak, Quantitative determination of prednisone in tablets by infrared attenuated total reflection and Raman spectroscopy, J. AOAC Int. 95(3) (2012) 744–750; https://doi.org/10.5740/jaoacint.sge_mazurek
- European Pharmacopoeia, 11th ed., European Directorate for the Quality of Medicines & Health-Care, Strasbourg 2022; last access date September 1, 2024.
- V. K. Prasad, B. Ho and C. Haneke, Simultaneous determination of prednisolone acetate, prednisolone, prednisone, cortisone and hydrocortisone in swine plasma using solid-phase and liquid--liquid extraction techniques, J. Chromatogr. B: Biomed. Sci. Appl. 378 (2016) 305–316; https://doi.org/10.1016/S0378-4347(00)80727-6
- N. S. Abdelhamid, M. A. Magdy, B. H. Anwar and N. F. Farid, US FDA-validated TLC method with four greenness assessment evaluations for simultaneous determination of prednisolone and esomeprazole in spiked human plasma, Biomed. Chromatogr. 36(5) (2022) e5343; https://doi.org/10.1002/bmc.5343
- I. A. Ionita, D. M. Fast and F. Akhlaghi, Development of a sensitive and selective method for the quantitative analysis of cortisol, cortisone, prednisolone and prednisone in human plasma, J. Chromatogr. B 877(8–9) (2009) 765–772; https://doi.org/10.1016/j.jchromb.2009.02.019
- H. Shibasaki, H. Nakayama, T. Furuta, Y. Kasuya, M. Tsuchiya, A. Soejima, A. Yamada and T. Nagasawa, Simultaneous determination of prednisolone, prednisone, cortisol, and cortisone in plasma by GC-MS: Estimating unbound prednisolone concentration in patients with nephrotic syndrome during oral prednisolone therapy, J. Chromatogr. B 870(2) (2008) 164–169; https://doi.org/10.1016/j.jchromb.2008.03.003
- M. Finšgar, A. Perva-Uzunalić, H. Behr, N. Ledinek, Z. Knez and Z. Novak, An improved reversed-phase high-performance liquid chromatography method for the analysis of related substances of prednisolone in active ingredient, ACS Omega 5(14) (2020) 7987–8000; https://doi.org/10.1021/acsomega.0c00037
- International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), ICH Q2(R2) Guideline on Validation of Analytical Procedures, Current Step 5 version, June 2024; https://www.ema.europa.eu/en/documents/scientific-guideline/ich-q2r2-guideline-validation-analytical-procedures-step-5-revision-1_en.pdf; last access date September 1, 2024
- F. Pena-Pereira, W. Wojnowski and M. Tobiszewski, AGREE-analytical GREEnness metric approach and software, Anal. Chem. 92(14) (2020) 10076–10082; https://doi.org/10.1021/acs.anal-chem.0c01887
- W. Wojnowski, M. Tobiszewski, F. Pena-Pereira and E. Psillakis, AGREEprep – Analytical greenness metric for sample preparation, Trends Anal. Chem. 149 (2022) Article ID 16553 (9 pages); https://doi.org/10.1016/j.trac.2022.116553
- F. R. Mansour, K. M. Omer and J. Płotka-Wasylka, A total scoring system and software for complex modified GAPI (ComplexMoGAPI) application in the assessment of method greenness, Green Anal. Chem. 10 (2024) Article ID 100126 (4 pages); https://doi.org/10.1016/j.greeac.2024.100126
- N. Manousi, W. Wojnowski, J. Płotka-Wasylka and V. F. Samanidou, Blue applicability grade index (BAGI) and software: A new tool for the evaluation of method practicality, Green Chem. 25 (2023) 7598–7604; https://doi.org/10.1039/d3gc02347h
- British Pharmacopoeia, The Stationery Office, London 2023; last access date September 1, 2024
- United States Pharmacopeia – National Formulary (USP 43–NF 38), United States Pharmacopeial Convention, Rockville, MD 2020; last access date September 1, 2024
- M. Kątny and M. Frankowski, Impurities in drug products and active pharmaceutical ingredients, Crit. Rev. Anal. Chem. 47(3) (2017) 187–193; https://doi.org/10.1080/10408347.2016.1242401
- J. Kovačić, D. Amidžić Klarić, N. Turk, Ž. Krznarić and A. Mornar, Development and validation of stability-indicating method of etrasimod by HPLC/DAD/MS/MS technique with greenness profiling, Heliyon 10(3) (2024) Article ID (14 pages) e34066; https://doi.org/10.1016/j.heliyon.2024.e34066
- J. Kovačić, D. Amidžić Klarić, N. Turk, Ž. Krznarić, E. Riordan and A. Mornar, The stability-indicating ultra high-performance liquid chromatography with diode array detector and tandem mass spectrometry method applied for the forced degradation study of ritlecitinib: An appraisal of green and blue metrics, Pharmaceuticals 18(1) (2025) Article ID 124 (18 pages); https://doi.org/10.3390/ph18010124